A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To examine the efficacy of saquinavir SGC (soft gel capsules) in combination with other
antiretrovirals in HIV-1 infected patients currently treated with saquinavir HGC (hard gel
capsules) measured by the absolute change in plasma HIV-1 RNA during the 24 weeks of study
treatment.